 [5] 
  The Applicant argues that the three part test has been confirmed in Abbott Laboratories v. Canada (Minister of Health) (2003), 29 C.P.R. (4th) 450 [“Abbott Laboratories”], as well as in AstraZeneca AB v. Apotex Inc. (2004), 36 C.P.R. (4th) 48 at para. 25; 2004 FC 1207 [“AstraZeneca”], and in Bayer AG v. Canada (Minister of Health and Welfare) (1994), 58 C.P.R. (3d) 377 at 380.